FDA Approves Ustekinumab Biosimilar Otulfi

The US Food and Drug Administration has approved ustekinumab-aauz (Otulfi), a biosimilar that references Johnson & Johnson’s ustekinumab (Stelara). This is the fourth ustekinumab biosimilar approved in the United States. Like the reference product, ustekinumab-aauz is indicated for: Patients 6 years or older with moderate to severe plaque psoriasis who are candidates for phototherapy or ...

https://teach.coursemateai.com/home/course/get-it-done/163 
Get In Touch

Cape Breton, NS

+012 345 67890

Chris@websurfer.ca

Follow Us
Flickr Photos

Copyright © 2023 cape-breton.com. Toady's News. All Rights Reserved